Table 1

Baseline characteristics of the study population at randomization

Insulin-treated groupTriple oral group
Age (years)44.75 ± 9.745.00 ± 10.7
Sex (male/female)20/917/12
Ethnicity
    African American12 (41)13 (45)
    White6 (20)4 (14)
    Hispanic11 (38)11 (38)
    Other0 (0)1 (3)
Weight (kg)102 ± 25101 ± 23
BMI (kg/m2)35.6 ± 6.636.5 ± 7.0
Systolic blood pressure (mmHg)125 ± 15.8123 ± 13.6
Diastolic blood pressure (mmHg)76 ± 10.478 ± 9.7
A1C (%)6.0 ± 0.55.9 ± 0.5
Fasting glucose (mg/dl)112 ± 24.7102 ± 19.1
Fasting insulin (μU/ml)25 ± 35.923 ± 22.0
Total cholesterol (mg/dl)170 ± 38.5171 ± 32.4
LDL cholesterol (mg/dl)97 ± 33.7102 ± 29.8
HDL cholesterol (mg/dl)41 ± 9.642 ± 10.8
Triglycerides (mg/dl)172 ± 159.3136 ± 73.0
  • Data are means ± SD or n (%).